Therefore this selective reduction is in accordance with the previous results, that have shown imbalance between pro and anti-apoptotic Bcl-2 family proteins, including caspase-3 activated, in Renca cells treated Amblyomin-X, but not in non-tumor cells [18]. The gene discussed is CASP3; the disease is neoplasm.